DAFNA Capital Management’s Procept Biorobotics PRCT Stock Holding History

DAFNA Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.71M	Hold	120,000	–	–	0.52%	39
2026 Q1	$3M	Hold	120,000	–	–	0.68%	36
2025 Q4	$3.78M	Buy	+120,000	New	+$3.98M	0.88%	29
2025 Q3	–	Sell	-3,000	Closed	-$173K	–	81
2025 Q2	$173K	Buy	+3,000	New	+$170K	0.05%	75
2024 Q3	–	Sell	-13,994	Closed	-$855K	–	86
2024 Q2	$855K	Sell	13,994 -41,001	-75%	-$2.44M	0.2%	63
2024 Q1	$2.72M	Sell	54,995 -8,305	-13%	-$395K	0.62%	39
2023 Q4	$2.65M	Sell	63,300 -4,000	-6%	-$136K	0.64%	39
2023 Q3	$2.21M	Buy	67,300 +59,300	+741%	+$2.02M	0.69%	36
2023 Q2	$283K	Buy	+8,000	New	+$265K	0.08%	68

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAFNA Capital Management's PRCT Position: Q2 2026 in Review

DAFNA Capital Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 120,000 shares worth $2.71M. The position accounts for 0.52% of the portfolio, ranked #39.

DAFNA Capital Management first reported a position in PRCT in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.78M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

DAFNA Capital Management held 120,000 shares of Procept Biorobotics worth $2.71M as of Q2 2026.
DAFNA Capital Management left its Procept Biorobotics share count unchanged in Q2 2026.
Procept Biorobotics made up 0.52% of DAFNA Capital Management's portfolio in Q2 2026, its #39 holding.
DAFNA Capital Management first reported a position in Procept Biorobotics in Q2 2023 and has held it in 9 quarters since.
DAFNA Capital Management's Procept Biorobotics position peaked at $3.78M in Q4 2025.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.